The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities
Abstract
Oligodeoxynucleotides (ODN) with unmethylated deoxycytidyl‐deoxyguanosine (CpG) dinucleotides (CpG ODN) mimic the immunostimulatory activity of bacterial DNA and are recognized by the Toll‐like receptor 9 (TLR9). CpG ODN of the B‐Class stimulate strong B cell and NK cell activation and cytokine production. The highest degrees of NK stimulation as well as IFN‐α secretion by plasmacytoid DC were found to occur only with A‐Class ODN. A third class of CpG ODN combines the immune effects of A‐ and B‐Class CpG ODN. C‐Class ODN strongly stimulate B cell or NK cell activation and IFN‐α production. In contrast to the A‐Class, the C‐Class is wholly phosphorothioate, has no poly‐G stretches, but has palindromic sequences combined with stimulatory CpG motifs. All classes stimulate TLR9‐dependent signaling, but with strikingly different dose‐response relationships that are quite in contrast to those observed for IFN‐α. Effects similar to those on human cells were observed on mouse splenocytes. In contrast, splenocytes from TLR9‐deficient mice did not show any response to the three CpG ODN classes. In vivo studies demonstrate that C‐Class ODN are very potent Th1adjuvants. C‐Class ODN may represent new therapeutic drugs that combine the effects of A‐ and B‐Class ODN for broad applications in infectious disease or cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
Self-citationA Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
CpG motifs in bacterial DNA trigger direct B-cell activation
Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M. (1995) · Nature · doi:10.1038/374546a0 · Cited by 3,508
Self-citationCpG Motifs in Bacterial DNA and Their Immune Effects
Krieg, A. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064842 · Cited by 2,573
Self-citationSmall anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway
Hemmi, H., Kaisho, T., Takeuchi, O., Sato, S., Sanjo, H., Hoshino, K., Horiuchi, T., Tomizawa, H., Takeda, K., & Akira, S. (2002) · Nature Immunology · doi:10.1038/ni758 · Cited by 2,522
Hornung, V., Rothenfusser, S., Britsch, S., Krug, A., Jahrsdörfer, B., Giese, T., Endres, S., & Hartmann, G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4531 · Cited by 1,935
Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition
Bauer, S., Kirschning, C. J., Häcker, H., Redecke, V., Hausmann, S., Akira, S., Wagner, H., & Lipford, G. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161293498 · Cited by 1,533
IRAK-M Is a Negative Regulator of Toll-like Receptor Signaling
Kobayashi, K., Hernandez, L. D., Galán, J. E., Janeway, C. A., Medzhitov, R., & Flavell, R. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00827-9 · Cited by 1,286
Yamamoto, M., Sato, S., Mori, K., Hoshino, K., Takeuchi, O., Takeda, K., & Akira, S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.12.6668 · Cited by 1,227
Krug, A., Rothenfusser, S., Hornung, V., Jahrsdörfer, B., Blackwell, S., Ballas, Z. K., Endres, S., Krieg, A. M., & Hartmann, G. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200107)31:7<2154::aid-immu2154>3.0.co;2-u · Cited by 882
Self-citationHuman TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848
Jurk, M., Heil, F., Vollmer, J., Schetter, C., Krieg, A. M., Wagner, H., Lipford, G., & Bauer, S. (2002) · Nature Immunology · doi:10.1038/ni0602-499 · Cited by 838
Self-citationThe adaptor molecule TIRAP provides signalling specificity for Toll-like receptors
Horng, T., Barton, G. M., Flavell, R. A., & Medzhitov, R. (2002) · Nature · doi:10.1038/nature01180 · Cited by 809
Ballas, Z. K., Rasmussen, W. L., & Krieg, A. M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.5.1840 · Cited by 754
Self-citationAhmad-Nejad, P., Häcker, H., Rutz, M., Bauer, S., Vabulas, R. M., & Wagner, H. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200207)32:7<1958::aid-immu1958>3.0.co;2-u · Cited by 717
Davis, H. L., Weeranta, R., Waldschmidt, T. J., Tygrett, L., Schorr, J., & Krieg, A. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.870 · Cited by 677
Self-citationMechanism and Function of a Newly Identified CpG DNA Motif in Human Primary B Cells
Hartmann, G., & Krieg, A. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.944 · Cited by 605
Self-citationHartmann, G., Weeratna, R. D., Ballas, Z. K., Payette, P., Blackwell, S., Suparto, I., Rasmussen, W. L., Waldschmidt, M., Sajuthi, D., Purcell, R. H., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.3.1617 · Cited by 585
Self-citationCutting Edge: Role of Toll-Like Receptor 9 in CpG DNA-Induced Activation of Human Cells
Takeshita, F., Leifer, C. A., Gursel, I., Ishii, K. J., Takeshita, S., Gursel, M., & Klinman, D. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.7.3555 · Cited by 570
Human Peripheral Blood Cells Differentially Recognize and Respond to Two Distinct CpG Motifs
Verthelyi, D., Ishii, K. J., Gursel, M., Takeshita, F., & Klinman, D. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2372 · Cited by 529
Häcker, H., Vabulas, R. M., Takeuchi, O., Hoshino, K., Akira, S., & Wagner, H. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.595 · Cited by 468
Hemmi, H., Kaisho, T., Takeda, K., & Akira, S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.3059 · Cited by 340
Recognition of CpG DNA is mediated by signaling pathways dependent on the adaptor protein MyD88
Schnare, M., Holt†, A. C., Takeda, K., Akira, S., & Medzhitov, R. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00700-4 · Cited by 252
Dalpke, A. H., Opper, S., Zimmermann, S., & Heeg, K. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7082 · Cited by 241
Gürsel, M., Verthelyi, D., Gürsel, I., Ishii, K. J., & Klinman, D. M. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.5.813 · Cited by 214
CpG Oligodeoxynucleotides as Vaccine Adjuvants in Primates
Verthelyi, D., Kenney, R. T., Seder, R. A., Gam, A. A., Friedag, B., & Klinman, D. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.4.1659 · Cited by 199
Häcker, H., Mischak, H., Häcker, G., Eser, S., Prenzel, N., Ullrich, A., & Wagner, H. (1999) · The EMBO Journal · doi:10.1093/emboj/18.24.6973 · Cited by 124
Redford, T. W., Yi, A., Ward, C. T., & Krieg, A. Μ. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.8.3930 · Cited by 89
Self-citationBlazar, B. R., Krieg, A. Μ., & Taylor, P. A. (2001) · Blood · doi:10.1182/blood.v98.4.1217 · Cited by 79
Self-citationCpG DNA: recognition by and activation of monocytes
Klinman, D. M., Takeshita, F., Gürsel, İ., Leifer, C. A., Ishii, K. J., Verthelyi, D. I., & Gürsel, M. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)01614-3 · Cited by 72
Recent advances in the development of immunostimulatory oligonucleotides.
Uhlmann, E., & Vollmer, J. (2003) · PubMed · Cited by 71
Self-citationHighly Immunostimulatory CpG-Free Oligodeoxynucleotides for Activation of Human Leukocytes
Vollmer, J., Janosch, A., Laucht, M., Ballas, Z. K., Schetter, C., & Krieg, A. Μ. (2002) · Antisense and Nucleic Acid Drug Development · doi:10.1089/108729002760220761 · Cited by 62
Self-citationLack of Immune Stimulation by Immobilized CpG-Oligodeoxynucleotide
Manzel, L. J., & Macfarlane, D. E. (1999) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1999.9.459 · Cited by 62
Use of CpG DNA for Enhancing Specific Immune Responses
Davis, H. L. (2000) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59672-8_12 · Cited by 56
Self-citationManzel, L. J., Strękowski, L., Ismail, F. M. D., Smith, J. C., & Macfarlane, D. E. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35244-9 · Cited by 31
Cited by
IPC: Professional Type 1 Interferon-Producing Cells and Plasmacytoid Dendritic Cell Precursors
Liu, Y.-J. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115633 · Cited by 1,625
Therapeutic potential of Toll-like receptor 9 activation
Krieg, A. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2059 · Cited by 1,246
Self-citationPlasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases
Gilliet, M., Cao, W., & Liu, Y.-J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2358 · Cited by 1,190
Targeting Toll-like receptors: emerging therapeutics?
Hennessy, E. J., Parker, A. E., & O'Neill, L. A. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3203 · Cited by 886
Beignon, A.-S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26032 · Cited by 673
Metadata
- Authors
- Vollmer, J., Weeratna, R., Payette, P., Jurk, M., Schetter, C., Laucht, M., Wader, T., Tluk, S., Liu, M., Davis, H. L., & Krieg, A. M.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2003-12-19
- Volume
- 34
- Issue
- 1
- Pages
- 251-262
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2087144130
- Cited by
- 595
- References
- 35
- FWCI
- 10.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.